{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:00:38Z","timestamp":1790136038739,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T00:00:00Z","timestamp":1632787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82070598"],"award-info":[{"award-number":["No. 82070598"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hereditary hemochromatosis (HH) is widely recognized and clinical manifestations of hemochromatosis-related (<jats:italic>HFE<\/jats:italic>-related) HH is well studied in European populations. Less is known about the clinical and laboratory characteristics of non-<jats:italic>HFE<\/jats:italic> related HH in Asian population. We aimed to explore the relationship between genotype and clinical phenotype in Chinese patients with non-<jats:italic>HFE<\/jats:italic> related hereditary hemochromatosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Peripheral blood samples and clinical data of patients with primary iron overload were collected from the China Registry of Genetic\/Metabolic Liver Diseases. Sanger sequencing was performed in cases with primary iron overload, for 5 known HH related genes (<jats:italic>HFE<\/jats:italic>, <jats:italic>HJV<\/jats:italic>, <jats:italic>HAMP<\/jats:italic>, <jats:italic>TFR2<\/jats:italic> and <jats:italic>SLC40A1)<\/jats:italic> and 2 novel iron homeostasis-related genes (<jats:italic>DENND3<\/jats:italic> and <jats:italic>SUGP2)<\/jats:italic>. The correlation of genotype and clinical phenotype in these patients was analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of the 32 patients with primary iron overload (23 were males and 9 were females), non-<jats:italic>HFE<\/jats:italic> variants were detected in 31 (31\/32, 97%), including 8 pathogenic variants in <jats:italic>HJV<\/jats:italic>, 7 pathogenic variants in <jats:italic>SLC40A1<\/jats:italic>, 8 likely pathogenic variants in <jats:italic>SUGP2<\/jats:italic> and 5 likely pathogenic variants in <jats:italic>DENND3<\/jats:italic> cases. Among these 31 cases, 4 cases harbored homozygous variants, 2 cases harbored homozygous\u2009+\u2009heterozygous variants, 19 cases harbored heterozygous or combined heterozygous variants, and 6 cases harbored no any damaging variants. None of investigated cases carried damaging <jats:italic>HAMP<\/jats:italic> and <jats:italic>TFR2<\/jats:italic> variants were found. 8 cases were classified as type 2A HH and 6 cases as type 4 HH, 10 cases as non-classical genotype, and 6 cases had no pathogenic variants from 31 cases. During the statistical analysis, we excluded one case (<jats:italic>SLC40A1<\/jats:italic> IVS3\u2009+\u200910delGTT\u2009+\u2009<jats:italic>SUGP2<\/jats:italic> p. R639Q(homo)) with difficulty in grouping due to combined damaging variants. Cases with type 2A HH have an earlier age at diagnosis (<jats:italic>p<\/jats:italic>\u2009=\u20090.007). The iron index of cases in type 2A HH and type 4 HH was higher than that in other groups (<jats:italic>p<\/jats:italic>\u2009=\u20090.01). Arthropathy was relatively rare in all groups. None of cases with type 2A HH developed cirrhosis. Cirrhosis and diabetes are more prevalent in type 4 HH. The incidence of cirrhosis (<jats:italic>p<\/jats:italic>\u2009=\u20090.011), cardiac involvement (<jats:italic>p<\/jats:italic>\u2009=\u20090.042), diabetes (<jats:italic>p<\/jats:italic>\u2009=\u20090.035) and hypogonadism (<jats:italic>p<\/jats:italic>\u2009=\u20090.020) was statistically significant in the four groups. However, due to the limited sample size, the pairwise comparison showed no significant difference.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This is the first comprehensive analysis about the gene variant spectrum and phenotypic aspects of non-<jats:italic>HFE<\/jats:italic> HH in China. The results will be useful to the identification, diagnosis and management of HH in China.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-02020-y","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T19:06:39Z","timestamp":1632855999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Correlation of genotype and phenotype in 32 patients with hereditary hemochromatosis in China"],"prefix":"10.1186","volume":"16","author":[{"given":"Liyan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4673-8890","authenticated-orcid":false,"given":"Jidong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,28]]},"reference":[{"issue":"2","key":"2020_CR1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1053\/j.gastro.2010.06.013","volume":"139","author":"A Pietrangelo","year":"2010","unstructured":"Pietrangelo A. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment. Gastroenterology. 2010;139(2):393\u2013408.","journal-title":"Gastroenterology"},{"issue":"3","key":"2020_CR2","first-page":"183","volume":"87","author":"BK Crownover","year":"2013","unstructured":"Crownover BK, Covey CJ. Hereditary hemochromatosis. Am Fam Physician. 2013;87(3):183\u201390.","journal-title":"Am Fam Physician"},{"issue":"2","key":"2020_CR3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1136\/flgastro-2017-100872","volume":"9","author":"M Pericleous","year":"2017","unstructured":"Pericleous M, Kelly C. The clinical management of hereditary haemochromatosis. Front Gastroenterol. 2017;9(2):110\u20134.","journal-title":"Front Gastroenterol"},{"issue":"2","key":"2020_CR4","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/0016-5085(91)90013-B","volume":"101","author":"PC Adams","year":"1991","unstructured":"Adams PC, Speechley M, Kertesz AE. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology. 1991;101(2):368\u201372.","journal-title":"Gastroenterology"},{"key":"2020_CR5","doi-asserted-by":"publisher","first-page":"18016","DOI":"10.1038\/nrdp.2018.16","volume":"4","author":"P Brissot","year":"2018","unstructured":"Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, Lor\u00e9al O. Haemochromatosis. Nat Rev Dis Primers. 2018;4:18016.","journal-title":"Nat Rev Dis Primers"},{"key":"2020_CR6","doi-asserted-by":"crossref","unstructured":"Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases. Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases. Hepatology. 2011;54(1): 328\u2013343.","DOI":"10.1002\/hep.24330"},{"issue":"23","key":"2020_CR7","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1056\/NEJMra031573","volume":"350","author":"A Pietrangelo","year":"2004","unstructured":"Pietrangelo A. Hereditary hemochromatosis-a new look at an old disease. N Engl J Med. 2004;350(23):2383\u201397.","journal-title":"N Engl J Med"},{"issue":"7","key":"2020_CR8","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1111\/jgh.12222","volume":"28","author":"CJ McDonald","year":"2013","unstructured":"McDonald CJ, Wallace DF, Crawford DH, Subramaniam VN. Iron storage disease in Asia-Pacific populations: the importance of non-HFE mutations. J Gastroenterol Hepatol. 2013;28(7):1087\u201394.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"2020_CR9","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12185-016-2150-8","volume":"105","author":"Y Wang","year":"2017","unstructured":"Wang Y, Du Y, Liu G, Guo S, Hou B, Jiang X, et al. Identification of novel mutations in HFE, HFE2, TfR2, and SLC40A1 genes in Chinese patients affected by hereditary hemochromatosis. Int J Hematol. 2017;105(4):521\u20135.","journal-title":"Int J Hematol"},{"issue":"10","key":"2020_CR10","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/jmedgenet-2018-105348","volume":"55","author":"T Lv","year":"2018","unstructured":"Lv T, Zhang W, Xu A, Li Y, Zhou D, Zhang B, et al. Non-HFE mutations in haemochromatosis in China: combination of heterozygous mutations involving HJV signal peptide variants. J Med Genet. 2018;55(10):650\u201360.","journal-title":"J Med Genet"},{"issue":"2","key":"2020_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12072-018-9855-0","volume":"12","author":"P Adams","year":"2018","unstructured":"Adams P, Altes A, Brissot P, Butzeck B, Cabantchik I, Can\u00e7ado R, et al. Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y\/C282Y) homozygous genotype. Hepatol Int. 2018;12(2):83\u20136.","journal-title":"Hepatol Int"},{"key":"2020_CR12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-61779-176-5_14","volume":"760","author":"C Dong","year":"2011","unstructured":"Dong C, Yu B. Mutation surveyor: an in silico tool for sequencing analysis. Methods Mol Biol. 2011;760:223\u201337.","journal-title":"Methods Mol Biol"},{"key":"2020_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-60761-947-5_10","volume":"688","author":"JA Minton","year":"2011","unstructured":"Minton JA, Flanagan SE, Ellard S. Mutation surveyor: software for DNA sequence analysis. Methods Mol Biol. 2011;688:143\u201353.","journal-title":"Methods Mol Biol"},{"issue":"5","key":"2020_CR14","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Gene Med. 2015;17(5):405\u201324.","journal-title":"Gene Med"},{"issue":"6","key":"2020_CR15","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/liv.14013","volume":"39","author":"W Zhang","year":"2019","unstructured":"Zhang W, Xu A, Li Y, Zhao S, Zhou D, Wu L, et al. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: a recurrent cause of haemochromatosis in China. Liver Int. 2019;39(6):1120\u20137.","journal-title":"Liver Int"},{"key":"2020_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3389\/fgene.2020.00077","volume":"11","author":"W Zhang","year":"2020","unstructured":"Zhang W, Wang X, Duan W, Xu A, Zhao X, Huang J, et al. HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case. Front Genet. 2020;11:77.","journal-title":"Front Genet"},{"issue":"1","key":"2020_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.annepidem.2010.05.013","volume":"21","author":"AM Neghina","year":"2011","unstructured":"Neghina AM, Anghel A. Hemochromatosis genotypes and risk of iron overload-a meta-analysis. Ann Epidemiol. 2011;21(1):1\u201314.","journal-title":"Ann Epidemiol"},{"issue":"1","key":"2020_CR18","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1182\/blood-2018-02-830562","volume":"132","author":"K Sandhu","year":"2018","unstructured":"Sandhu K, Flintoff K, Chatfield MD, Dixon JL, Ramm LE, Ramm GA, et al. Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease. Blood. 2018;132(1):101\u201310.","journal-title":"Blood"},{"issue":"4","key":"2020_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/cen.12529","volume":"82","author":"BB Yeap","year":"2015","unstructured":"Yeap BB, Divitini ML, Gunton JE, Olynyk JK, Beilby JP, McQuillan B, et al. Higher ferritin levels, but not serum iron or transferrin saturation, are associated with Type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Clin Endocrinol (Oxf). 2015;82(4):525\u201332.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"5","key":"2020_CR20","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s11892-014-0488-y","volume":"14","author":"T Creighton Mitchell","year":"2014","unstructured":"Creighton Mitchell T, McClain DA. Diabetes and Hemochromatosis. Curr Diab Rep. 2014;14(5):488.","journal-title":"Curr Diab Rep"},{"issue":"3","key":"2020_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jdiacomp.2007.11.006","volume":"23","author":"M Afkhami-Ardekani","year":"2009","unstructured":"Afkhami-Ardekani M, Rashidi M. Iron status in women with and without gestational diabetes mellitus. J Diabetes Compl. 2009;23(3):194\u20138.","journal-title":"J Diabetes Compl"},{"issue":"1","key":"2020_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3132\/dvdr.2008.003","volume":"5","author":"F Sharifi","year":"2008","unstructured":"Sharifi F, Nasab NM, Zadeh HJ. Elevated serum ferritin concentrations in prediabetic subjects. Diab Vasc Dis Res. 2008;5(1):15\u20138.","journal-title":"Diab Vasc Dis Res"},{"issue":"3","key":"2020_CR23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1056\/NEJMoa073286","volume":"358","author":"KJ Allen","year":"2008","unstructured":"Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, et al. Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med. 2008;358(3):221\u201330.","journal-title":"N Engl J Med"},{"issue":"1","key":"2020_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11926-013-0393-4","volume":"16","author":"E Husar-Memmer","year":"2014","unstructured":"Husar-Memmer E, Stadlmayr A, Datz C, Zwerina J. HFE-related hemochromatosis: an update for the rheumatologist. Curr Rheumatol Rep. 2014;16(1):393.","journal-title":"Curr Rheumatol Rep"},{"issue":"5","key":"2020_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.5604\/01.3001.0010.2815","volume":"16","author":"JC Barton","year":"2017","unstructured":"Barton JC, Barton JC, Adams PC. Clinical and Laboratory Associations with Persistent Hyperferritinemia in 373 Black Hemochromatosis and Iron Overload Screening Study Participants. Ann Hepatol. 2017;16(5):802\u201311.","journal-title":"Ann Hepatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-02020-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-02020-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T19:28:02Z","timestamp":1632857282000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-02020-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,28]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2020"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-02020-y","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,28]]},"assertion":[{"value":"20 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Beijing Friendship Hospital, Capital Medical University (No. 2016-P2-061-01). Informed and written consent was obtained for the study from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed on the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"398"}}